Meridian Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$329K Sell
6,839
-439
-6% -$20.5K 0.01% 624
2025
Q4
$353K Sell
7,278
-38,263
-84% -$1.9M 0.01% 584
2025
Q3
$2.15M Sell
45,541
-30
-0.1% -$1.45K 0.08% 209
2025
Q2
$2.2M Buy
45,571
+1,398
+3% +$71.4K 0.09% 190
2025
Q1
$2.45M Buy
44,173
+391
+0.9% +$21.2K 0.12% 169
2024
Q4
$2.11M Buy
43,782
+1,413
+3% +$71.8K 0.1% 182
2024
Q3
$2.44M Buy
42,369
+4,972
+13% +$268K 0.12% 167
2024
Q2
$1.81M Buy
+37,397
New +$1.8M 0.22% 84
2024
Q1
Sell
-33,695
Closed -$1.68M 475
2023
Q4
$1.68M Buy
+33,695
New +$1.65M 0.11% 186
2019
Q3
Sell
-1,630
Closed -$705 440
2019
Q2
$705 Buy
+1,630
New +$69.3K 0.03% 322

Other funds holding SNY

Meridian Wealth Management's SNY Position: Q1 2026 in Review

Meridian Wealth Management reduced its Sanofi (SNY) stake by 6% in Q1 2026, selling an estimated $20.5K and leaving 6,839 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #624.

Meridian Wealth Management first reported a position in SNY in Q2 2019 and has held it in 10 quarters since. The position peaked at $2.45M in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Meridian Wealth Management held 6,839 shares of Sanofi worth $329K as of Q1 2026.
  • Meridian Wealth Management sold 439 Sanofi shares in Q1 2026, an estimated $20.5K.
  • Sanofi made up 0.01% of Meridian Wealth Management's portfolio in Q1 2026, its #624 holding.
  • Meridian Wealth Management first reported a position in Sanofi in Q2 2019 and has held it in 10 quarters since.
  • Meridian Wealth Management's Sanofi position peaked at $2.45M in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Meridian Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.